NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2033200293

Registered date:13/01/2021

An extension study of JR-031 in infants with neonatal hypoxic ischemic encephalopathy (hereinafter referred to as nHIE) for which hypothermia therapy is indicated

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedneonatal hypoxic ischemic encephalopathy (nHIE)
Date of first enrollment22/02/2021
Target sample size13
Countries of recruitment
Study typeObservational
Intervention(s)None

Outcome(s)

Primary OutcomeKyoto Scale of Psychological Development 2001
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum> 1age old
Age maximum< 2age old
GenderBoth
Include criteriaAn infant whose parent (legal representative) provides written informed consent
Exclude criteriaAn infant who, in the opinion of the investigator or subinvestigator, is not appropriate for the study

Related Information

Contact

Public contact
Name Tatsuyoshi Yamamoto
Address 11-18 Kusunoki-cho, Ashiya, Hyogo Hyogo Japan 659-0015
Telephone +81-797-32-8582
E-mail clinical_development@jp.jcrpharm.com
Affiliation JCR Pharmaceuticals Co., Ltd.
Scientific contact
Name Tatsuyoshi Yamamoto
Address 11-18 Kusunoki-cho, Ashiya, Hyogo Hyogo Japan 659-0015
Telephone +81-797-32-8582
E-mail clinical_development@jp.jcrpharm.com
Affiliation JCR Pharmaceuticals Co., Ltd.